If you have ever read “squalane” and “squalene” on the same shelf and wondered which one your supplier actually put in the bottle, you are not alone: the two names are one letter apart, chemically different, and not interchangeable on a label. Squalane is a stable, plant-friendly emollient that has moved from a quiet supporting lipid to a headline ingredient, and the questions that decide a compliant, credible squalane product are about naming, sourcing and concentration rather than “strength.”
This guide breaks down what squalane actually does, the sourcing rule that matters most (the EU’s move away from shark-derived squalene), the concentration ranges that appear in real formulas, and the compatibility decisions that decide whether a squalane-led range looks consistent on the shelf. The reference platform is Lanthome’s Squalane Artemisia Cream Mugwort Rice Essence Skin Care Set — a private label skin care set (model CP83-SP) whose ingredient direction pairs squalane with artemisia, rice and niacinamide across cream and essence formats — and we use it as the concrete example whenever the chemistry gets practical. It sits in the Skin Care Set collection, which is the natural home for a coordinated botanical range.
Squalane is a saturated liquid oil. Its parent, squalene, is the unsaturated triterpene that human skin produces as part of sebum, and which many organisms — including certain deepwater sharks, whose liver oil historically supplied the industry — carry at high concentration. Squalane is what you get when squalene is hydrogenated: the double bonds are removed, the molecule becomes saturated, and with that one chemical step most of squalene’s problems go away. Squalene is reactive and prone to oxidizing; squalane is stable and slow to degrade. That single distinction is the reason the ingredient sits in finished products in the squalane form.
This is also why the product’s own listing asks the question buyers should be asking: should squalane or squalene appear on the finished label? The answer is that they are different INCI entries, not two spellings of the same thing, and the label must carry the exact name of the form actually used. “Squalane” on a spec sheet means the hydrogenated, stable oil; “Squalene” would mean the unsaturated precursor. A brand that cannot tell the two apart is likely discovering it on the shelf, not at the bench.
The second distinction that matters for a “natural” or “vegan” positioning — which is exactly the lane the reference set is named toward — is biosourcing. Squalene and squalane can be derived from shark liver oil, or from plant and fermentation sources such as olive, sugarcane, rice bran and amaranth, and increasingly from yeast. The molecule is the same regardless of source, but the sourcing story is not, and it is the sourcing story that drives the regulatory section below and the label claims a brand is allowed to make. The reference set’s theme — artemisia, mugwort, rice — is a botanical one, and squalane is the stable, non-irritating lipid that lets that botanical direction sit in a clean, well-tolerated base.
Here is where squalane marketing usually outruns the mechanism, so let us separate what the chemistry actually supports from what labels tend to promise.
Squalane’s core, well-documented function is that of an emollient and a mild occlusive. As an emollient, it sits in the surface film, smooths the look of skin, and softens the rough feel that comes with a stressed moisture barrier. As a light occlusive, it helps reduce the rate at which water escapes from the surface — the same transepidermal water loss (TEWL) logic that drives most moisturizer claims. Because squalene is already a native component of human sebum, squalane is often described as “skin-compatible,” and that phrasing is legitimate at the level of skin feel and tolerance: it spreads easily, is oil-based, and is generally well tolerated across skin types.
What squalane is not is a dose-responsive “active” in the way a tyrosinase inhibitor or a retinoid is. It does not brighten, exfoliate or visibly “repair” on its own; it is the medium that makes the rest of the formula feel pleasant, spreadable and gentle. That is a feature, not a weakness — it is what makes squalane the ingredient you put behind an entire botanical range rather than a single spot treatment. The conservative, defensible register is the same as for every ingredient we have covered: “commonly used as a moisturizing emollient,” “may help support the look of hydrated, soft skin,” “designed to feel light and non-greasy.” Off-limits is the implied-treatment register — “heals,” “restores the barrier,” “clinically proven moisturization” — which is the difference between a shippable label and a compliance problem. The boundary is the verb, not the ingredient.
The Cosmetic Ingredient Review (CIR) maintains published safety assessments for the squalane/squalene family and is the reference point for US market safety questions; the practical takeaway for a buyer is that the ingredient is regarded as low-risk in cosmetic use, which is precisely why so many “sensitive” and “minimalist” formulas lean on it.
The one regulatory point that matters more than any other for a squalane product is the sourcing route, and it is a story about conservation as much as about cosmetics.
The shark question. Squalene has historically been extracted from shark liver oil, and the pressure on vulnerable deepwater shark species has made that an increasingly hard-to-defend sourcing choice. The European Union has tightened rules on shark-derived products, and shark-derived squalene and squalane are no longer a viable route for cosmetics placed on the EU market. The practical consequence for a private label brand is straightforward: an EU-bound squalane product should be built on a plant- or fermentation-derived source (olive, sugarcane, rice bran, amaranth or yeast), and the raw material documentation should be able to prove it. This is the single biggest reason “squalane” quietly became “plant-derived squalane” across the category over the last few years.
EU framework. The EU’s overall obligations are set by the EU Cosmetics Regulation (EC) No 1223/2009: a product safety assessment, CPNP notification before market placement, and labeling that lists ingredients by their exact INCI name. None of that is new, but it is where the squalane-specific work lands — the INCI name must be the real form used (squalane, not a generic), and if the brand makes a “natural” or “organic” claim, that claim needs its own substantiation. The COSMOS standard is the widely referenced framework for organic and natural cosmetic claims, and a “herbal natural” brief like the reference set should be checked against whichever certification a brand actually intends to claim — a “natural” label without the documentation behind it is a claim the brand is carrying, not one the factory can underwrite.
US — no ban, claim discipline instead. In the United States, the FDA regulates cosmetics by safety and claims rather than by concentration caps, and there is no squalane-specific prohibition. The constraint is the cosmetic/drug boundary: a “moisturizes” or “helps support the look of hydrated skin” statement stays on the cosmetic side; language that implies treatment or repair of a condition drifts toward drug territory. Under the modernized framework (MoCRA), the operational obligations a private label brand actually touches are facility registration, product listing and adverse-event reporting, and a reputable OEM partner will already be structured for them.
| Market | Position on squalane | Practical implication |
|---|---|---|
| EU / EEA | Shark-derived squalene/squalane no longer a viable cosmetic route; plant/fermentation-derived expected; standard 2009/1223 obligations apply | Source plant-derived squalane, keep the sourcing documentation, and substantiate any natural/organic claim |
| US | No squalane-specific ban; claims must stay cosmetic | Any biosource is acceptable; claim language is the constraint |
| Other markets | INCI naming; local restriction checks apply | Plant-derived is the safe, marketable default |
Two labeling notes follow. First, the INCI name on the label is the exact form and, for transparency, ideally the biosource story a brand can support — “Squalane” is the minimum, and “Squalane (olive-derived)” is the stronger, shippable claim when the COA backs it. Second, for multi-market brands, the EU is the one to design around: a formula built on plant-derived squalane is compliant for the EU and marketable everywhere, while a shark-derived version is a dead end in the EU from the start.
The commercial record for squalane is unusually wide, which is a direct consequence of the fact that it is a lipid rather than a dose-sensitive active. The same ingredient appears in several very different roles:
Three practical conclusions follow for a buyer:
| Product format | Typical squalane role | Typical level | Buyer consideration |
|---|---|---|---|
| Cream / serum | Secondary moisturizing lipid | ~1–15% | Confirms texture and occlusion, not potency |
| Facial oil | Primary vehicle | 100% or near | The whole base is squalane; actives dosed in |
| Balm / stick | Emollient base | Balanced with waxes/butters | Feel and melt point driven by the lipid blend |
The buyer takeaway is that squalane concentration is a formulation choice about feel and platform, not a strength statement. When you evaluate a squalane-led set, the question is not “how much squalane” but “which components carry it, at what level, and what the COA says about purity.”
Most of the “hard actives” in our ingredient guides are hard because they oxidize, drift in color, or fight each other on pH. Squalane is almost the opposite, and that is a genuine commercial advantage for a range you want to keep on the shelf for a long time.
Why it is stable. The hydrogenation step that turns squalene into squalane removes the double bonds that make squalene reactive. Saturated squalane is resistant to oxidation, carries no rancidity in the way an unsaturated oil can, and has essentially no odor. A formula built on squalane does not need the aggressive antioxidant insurance a polyunsaturated oil does, and it does not “turn” over time the way a high-dose botanical or a peroxidizing oil can.
What that means for a set. The reference platform is a cream-plus-essence set, which is a format that lives or dies on consistency across components and across a shelf life. Squalane is a forgiving base for exactly that: the same lipid in the cream and in the essence helps the range feel coherent, and the stability means the components age predictably rather than developing off-notes. This is part of why squalane shows up so often in “clean,” “minimal” and “sensitive-skin” positions — it is a low-drama ingredient that does not create new failure modes.
Two things to still manage. First, because squalane is oil-soluble, a “squalane essence” or a water-based serum with squalane is a question of emulsification and phase, not just concentration — confirm how the lipid is carried in each component so the texture the label promises is the texture the bottle actually delivers. Second, a plant-derived squalane with “natural” positioning should still get the normal stability review (accelerated and long-term cycles with appearance, odor and pH checkpoints), because “stable ingredient” describes the molecule, not the finished multi-component set.
What to request from any OEM partner, in writing: the squalane biosource, the COA with purity, the level in each component of a set, and the stability summary for the finished formula. A manufacturer that answers all four is treating squalane as a controlled ingredient rather than a marketing word.
The practical reason brands reach for squalane is that it is one of the easier lipids to combine — it does not force a routine redesign and it does not fight most of the actives a modern range carries. The pairings worth understanding:
The reference set carries niacinamide alongside squalane, and it is a clean pairing: niacinamide does the tone-and-barrier work, squalane does the surface feel. There is no pH conflict to manage the way there is between two acidic actives, which is one reason this combination is so common in “calm, even, hydrated” positioning. Our niacinamide ingredient guide walks through where niacinamide sits in a multi-active system.
The CP83-SP set is a botanical story — artemisia, mugwort and rice — and squalane is the ideal carrier for that story because it is light, stable and non-irritating. Botanical extracts bring the “natural direction” and the brand narrative; squalane keeps the texture clean and the shelf life predictable. The one discipline: botanical extracts can vary batch to batch, so the squalane base should be specified tightly enough that a botanical variance does not change the feel of the finished product.
Both are stable, water-side actives that play well with an oil base: squalane adds the occlusive layer on top of what peptides and hyaluronic acid do at the surface. This is the architecture behind most “hydrating and firming” serums, and it is a low-risk combination from a stability standpoint.
Squalane is frequently used as the soothing base for a range that carries a more reactive active such as a retinoid, because its light, non-irritating feel offsets the texture burden. That is a texture and comfort pairing, though — the retinoid carries its own concentration and stability rules, so squalane does not relax those. For the reactive-active side of that equation, our blue copper peptide serum manufacturer guide covers the multi-active decision framework that applies to any reactive-active range.
| Co-ingredient | Interaction to manage | Typical formulation response |
|---|---|---|
| Niacinamide | Minimal — no pH conflict | Standard combination in “calm + hydrated” positioning |
| Botanical extracts | Batch variance | Specify the squalane base tightly so feel stays consistent |
| Peptides / hyaluronic acid | Minimal — stable water-side actives | Squalane as the occlusive layer on top |
| Retinoid / reactive active | Texture burden, not chemistry | Squalane as a soothing, light base |
The pattern across the table is the same as in our other ingredient guides: compatibility is not a property of the ingredient pair, it is a property of the finished formula. For a botanical set, that is exactly why the “easy” oil earns its place as the range’s backbone.
Let us make this concrete with the reference product: Lanthome’s Squalane Artemisia Cream Mugwort Rice Essence Skin Care Set.
The platform is a private label skin care set, model CP83-SP (product reference 1601596817430), for the face, with OEM customization supported and a base price shown at $4.00. The listing’s product overview describes it as a botanical direction for a private label facial collection, naming cream and essence formats with artemisia, rice, niacinamide and squalane among the ingredient references, and the presentation color is green. The component sizing spans 30 ml, 50 ml, 90 ml, 100 ml and 200 ml (plus an “other” option), which is the range that lets a buyer build a kit business model: a 30 ml essence for the trial tier, a 100 ml cream for the core SKU, and a 200 ml bottle for the home-care anchor, all under one visual identity.
Read as an architecture, the specification divides the roles deliberately:
Two buyer questions come straight from the product page itself, and they are the questions every serious buyer should ask about any botanical set:
First, squalane and squalene are named as distinct, and the exact ingredient declaration should be confirmed for each proposed formula rather than treating the two names as interchangeable across the range. The label must carry the exact INCI name of the form actually used — for an EU-bound product, that is also the point at which the plant-derived sourcing story has to be documented.
Second, the set’s ingredient theme does not mean every cream or essence has an identical formula. The botanical identity (which components actually contain artemisia, mugwort or rice) should be confirmed from the individual ingredient lists before any label highlights those names, because a set name is not an ingredient guarantee for every bottle inside the box.
The third, quieter question is about the positioning claim itself. The product overview points buyers to specify their ingredient preferences and the sourcing documentation they require, and to agree the supported wording before adding a natural-content statement or an organic claim to the artwork. That is the right order: the claim follows the documentation, not the other way around. If this shape fits your plan, the Skin Care Set collection shows the full range of coordinated private label kits available for customization, from botanical sets to hydrating gift ranges.
Before you commit a squalane product or set to production, put these questions in writing:
These questions do not cost anything to ask, and they filter out most of the suppliers that cannot answer them. You can reach the Lanthome team directly through the Contact Us page — a question with a biosource, a purity, a per-component level and a target market attached gets a faster, sharper answer than a generic inquiry. And if you want to understand what the manufacturing side of this looks like — factory capabilities, project structure, how OEM/ODM engagements are organized — the About Us page covers Lanthome’s background and services.
What is the difference between squalane and squalene?
Squalene is the unsaturated oil that skin produces as part of sebum; squalane is the hydrogenated, saturated version used in finished products because it is far more stable and less likely to oxidize. They are different INCI names and are not interchangeable on a label — confirm which one your formula actually contains.
Is squalane vegan?
Squalane can be. The molecule is identical whether it comes from plant or fermentation sources (olive, sugarcane, rice bran, amaranth, yeast) or from shark liver oil, so “vegan” is a sourcing statement, not a chemistry statement. A brand making a vegan or plant-derived claim should hold the raw material documentation that proves the source.
Is squalane a treatment or a moisturizer?
It is a moisturizing emollient and a light occlusive, not a dose-responsive active. It helps with the look and feel of hydrated, soft skin and supports the surface film, but it does not brighten, exfoliate or visibly “repair” on its own. The claims a label can make should stay in that cosmetic register.
How much squalane should a formula contain?
There is no efficacy threshold, because squalane is about feel and platform, not potency. In a cream or serum it is commonly a secondary lipid in the low single digits up to roughly 10–15%; in a facial oil it can be the entire vehicle. The right level depends on the format and the texture the product is designed to deliver.
Why did the industry move away from shark-derived squalene?
Shark-derived squalene comes from shark liver oil and has come under conservation pressure, and the European Union has tightened rules on shark-derived products so that shark-derived squalene and squalane are no longer a viable route for EU-bound cosmetics. Plant- and fermentation-derived squalane is now the standard, and it is also the version that supports a clean, vegan positioning.
Can squalane be used with niacinamide, botanicals or a retinoid?
In a well-managed formula, yes. It is a low-conflict lipid that pairs cleanly with niacinamide, stable water-side actives and botanical extracts, and it is often used as the soothing base for a range that carries a more reactive active such as a retinoid. The retinoid still carries its own concentration and stability rules — squalane manages the texture, not the reactive active.
How do I launch a private label squalane set?
Start from a set platform such as the CP83-SP reference in this article, confirm the per-component ingredient allocation and the squalane biosource and level in each bottle, fix the natural or vegan claim against the documentation you hold, review the stability summary, and sample every component before bulk. The sampling round trip is the step that catches most problems cheaply.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.